Close-up of microscope and sample with blue glove.

Funding excellent research

Aiming for a life without EB

EB Resnet supports and coordinates research funding on behalf of its member patient organisations and partners. We currently offer three funding schemes: Research grants through scheduled Calls for proposals, Ad-hoc grants our flexible funding scheme, and Co-funding for industry-partnering projects.

EB Resnet welcomes proposals for innovative research and clinical development of treatments or diagnostics. All proposals are evaluated for scientific excellence, feasibility and value for money, and whether they address the priority needs of people with EB. We undertake peer review to ensure that only the best research is funded.

Our funding schemes. How do your ideas fit in?

Research grants	Ad-hoc grants	Industry co-funding
You are engaged in fundamental to preclinical research in EB Your project idea falls within the scope of a Current /Closed Special Call (All priorities Call or Special Call in spring and/or autumn) You are working in academia, or in a clinic (cooperation with industry welcome) Your project objectives can be achieved in 12 to 36 months and financed with up to EUR 90,000.00 p.a.	You are engaged in fundamental research to preclinical research in EB You are in need of quick funding to respond to an arising opportunity in fundamental to preclinical research or proof of concept project (including databased initiatives and studies) You are working in academia, in a clinic or in industry Your project can be undertaken within one year (renewable if results are promising) and financed with up to EUR 90,000.00 p.a.	You are engaged in translational research and undertaking clinical trials in EB Your project is in late preclinical to clinical stage You are working in the industry and/or in cooperation with academia The project needs additional funding of up to EUR 250,000.00 to be realised

Research grants

Ad-hoc grants

Industry co-funding

Closed Research Grant Call

AP Call 2024

Open until 15th November 2024

Open

You are engaged in fundamental to preclinical research in EB
Your project idea falls within the scope of a Current /Closed Special Call (All priorities Call or Special Call in spring and/or autumn)
You are working in academia, or in a clinic (cooperation with industry welcome)
Your project objectives can be achieved in 12 to 36 months and financed with up to EUR 90,000.00 p.a.

You are engaged in fundamental research to preclinical research in EB
You are in need of quick funding to respond to an arising opportunity in fundamental to preclinical research or proof of concept project (including databased initiatives and studies)
You are working in academia, in a clinic or in industry
Your project can be undertaken within one year (renewable if results are promising) and financed with up to EUR 90,000.00 p.a.

You are engaged in translational research and undertaking clinical trials in EB
Your project is in late preclinical to clinical stage
You are working in the industry and/or in cooperation with academia
The project needs additional funding of up to EUR 250,000.00 to be realised

Closed Call 2024, and Special Call 2023

Submissions for the AP Call 2024 closed on September 09 and the Expert Meeting is planned for December 2024. Evaluation of proposals submitted to the Special Call 2023 focusing on chronic inflammation and fibrosis (CIF), cancer initiation & repurposing, which EB Resnet member DEBRA Austria is jointly funding with LifeArc, is completed - results will be published shortly.

The AP Call and the Special Ad-hoc Call from 2022 have both been completed. Results of the funded projects can be found in the overview tables 2022.

AP Call 2024 - CLOSED

All details about the All Priorities Call 2024 available here.

Special Call 2023

Joint Call 2023: Repurposing therapies for EB - EOI & Full Application CLOSED